Načítá se...
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
BACKGROUND: The outbreak and pandemic of coronavirus SARS-CoV-2 caused significant threaten to global public health and economic consequences. It is extremely urgent that global people must take actions to develop safe and effective preventions and therapeutics. Nanobodies, which are derived from si...
Uloženo v:
| Vydáno v: | J Nanobiotechnology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7844813/ https://ncbi.nlm.nih.gov/pubmed/33514385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00768-w |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|